Clinical trials recruiting for GastroEsophageal Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| DA-3501 | 1 |
| Extended Dosing Interval - A | 1 |
| Extended Dosing Interval - B | 1 |
| Extended Dosing Interval - C | 1 |
| MDX2001 | 1 |
| Zanidatamab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 3 |
| Colorado | 2 |
| Florida | 2 |
| Tennessee | 2 |
| Arizona | 1 |
| Illinois | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| New York | 1 |
| Pennsylvania | 1 |
| Virginia | 1 |
Top cities
Self-screener
Recruiting trials
- A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sample Collection for Ongoing Research and Product Evaluation Study
Related conditions
Trials recruiting for GastroEsophageal Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for GastroEsophageal Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.